Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria - A population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group

British Journal of Haematology

Volumn 144, Issue 4, 2009, Pages 559-570

  Reismüller, Bettina ^a   Attarbaschi, Andishe ^a   Peters, Christina ^a   Dworzak, Michael N ^a   Pötschger, Ulrike ^a   Urban, Christian ^b   Fink, Franz Martin ^c   Meister, Bernhard ^c   Schmitt, Klaus ^d   Dieckmann, Karin ^e   Henze, Günter ^f   Haas, Oskar A ^a   Gadner, Helmut ^a   Mann, Georg ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy; Relapse; Risk factors; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENETIC TRAIT; HUMAN; IMMUNOPHENOTYPING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRIA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 58549100672     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07499.x     Document Type: Article

References (38)

1. Aricó, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., Pui, C.H. Masera, G. (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. New England Journal of Medicine, 342, 998 1006.
2. Attarbaschi, A., Mann, G., Dworzak, M., Urban, C., Fink, F.M., Dieckmann, K., Riehm, H. Gadner, H. (2002) Treatment results of childhood acute lymphoblastic leukemia in Austria - a report of 20 years' experience. Wiener Klinische Wochenschrift, 114, 148 157.
3. Attarbaschi, A., Mann, G., Konig, M., Dworzak, M.N., Trego, M.M., Muhlegger, N., Gadner, H. Haas, O.A. (2004) Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia, 18, 1611 1616.
4. Attarbaschi, A., Mann, G., Strehl, S., König, M., Steiner, M., Jeitler, V., Lion, T., Dworzak, M., Gadner, H. Hass, O. (2007) Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6/RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia, 21, 584 586.
5. Barrett, A.J., Horowitz, M.M., Pollock, B.H., Zhang, M.-J., Bortin, M.M., Buchanan, G.R., Camitta, B.M., Ochs, J., Graham-Pole, J., Rowlings, P.A., Rimm, A.A., Klein, J.P., Shuster, J.J., Sobocinski, K.A. Gale, R.P. (1994) Bone marrow transplantes from HLA-identical siblingsas compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New England Journal of Medicine, 331, 1253 1258.
6. Behrendt, H., VanLeeuwen, E.F., Schuwirth, C., Verkes, R.J., Hermans, J., VanDerDoes-VanDenBerg, A. VanWering, E.R. (1989) The significance of an isolated central nervous system relapse occuring as first relapse in children with acute lymphoblastic leukemia. Cancer, 63, 2066.
7. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. van't-Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783 1786.
8. Borgmann, A., vonStackelberg, A., Hartmann, R., Ebell, W., Klingebiel, T., Peters, C. Henze, G. (2003) Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood, 101, 3835 3839.
9. Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M.G., Ludwig, W.D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F., Basso, F., Masera, G., Harbott, J. Biondi, A. (1997) Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatirca and the Berlin-Frankfurt-Munster Study Group. Blood, 90, 571 577.
10. Buchanan, G.R., Riviera, G.K., Pollock, B.H., Boyett, J.M., Chauvenet, A.R., Wagner, H., Maybee, D.A., Crist, W.M. Pinkel, D. (2000) Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: Pediatric Oncology Group study. Cancer, 88, 1166 1174.
11. Chessells, J.M., Veys, P., Kempsiki, H., Henley, P., Leiper, A., Webb, D. Hann, I.M. (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukemia. British Journal of Haematology, 123, 396 405.
12. Dopfer, R., Henze, G., Bender-Götze, C., Ebell, W., Ehninger, G., Friedrich, W., Gadner, H., Klingebiel, T., Peters, C., Riehm, H., Suttorp, M., Schmid, H., Schmitz, N., Siegert, W., Stollmann-Gibbels, B., Hartmann, R. Niethammer, D. (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood, 78, 2780 2784.
13. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hählen, K., Göbel, U., Klingebiel, T., Ludwig, W.D. Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. Journal of Clinical Oncology, 23, 7942 7950.
14. Erba, E., Serafini, M., Gaipa, G., Tognon, G., Marchini, S., Celli, N., Rotilio, D., Broggini, M., Jimeno, J., Fairchloth, G.T., Biondi, A. D'Incalci, M. (2003) Effect of Aplidin in acute lymphoblastic leukaemia cells. British Journal of Cancer, 89, 763 773.
15. Gadner, H., Krepler, P., Kummer, M., Pawlovsky, J., Schmidmeier, W., Haas, O.A., Gruemayer, E.R., Ausserer, B., Bettelheim, P. Grienberger, H. (1985) Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria - report of 10 years' experience. Wiener Klinische Wochenschrift, 97, 140 148.
16. Gaynon, P.S., Qu, R.P., Chappel, R.J., Willioughby, M.L.N., Tubergen, D.G., Steinherz, P.G. Trigg, M.E. (1998) Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse - the Children's Cancer Group Experience. Cancer, 82, 1387 1395.
17. Gaynon, P.S., Harris, R.E., Altman, A.I., Bostron, B.C., Breneman, J.C., Hawks, R., Steele, D., Zipf, T., Stram, D.O., Villaluna, D. Trigg, M.E. (2006) Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group Study CCG-1941. Journal of Clinical Oncology, 24, 3150 3156.
18. Harrison, C.J. Foroni, L. (2002) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology, 6.2, 91 113.
19. Harrison, G., Richards, S., Lawson, S., Darbyshire, P., Pinkerton, R., Stevens, R., Oakhill, A. Eden, O.B. (2000) Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukemia in the MRC UKALL R1 trial. Annals of Oncology, 11, 999 1006.
20. Heerema, N.A., Arthur, D.C., Sather, H., Albo, V., Feusner, J., Lange, B.J., Steinherz, P.G., Zeltzer, P., Hammond, D. Reaman, G.H. (1994) Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood, 83, 2274 2284.
21. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Janka-Schaub, G., Niethammer, D. Riehm, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood, 78, 1166 1172.
22. Jeha, S., Gaynon, P.S., Razzouk, B.I., Franklin, J., Kadota, R., Shen, V., Luchtman-Jones, L., Rytting, M., Bomgaars, L.R., Rheingold, S., Ritchey, K., Albano, E., Arceci, R.J., Goldman, S., Griffin, T., Altman, A., Gordon, B., Steinherz, L., Weitman, S. Steinherz, P. (2006) Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of Clinical Oncology, 24, 1917 1923.
23. Kaplan, E.M. Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
24. Klein, J.P., Rizzo, J.D., Zang, M.J. Keiding, N. (2001) Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplantation, 28, 1001 1011.
25. Lawson, S.E., Harrison, G., Richards, S., Oakhill, A., Stevens, R., Eden, O.B. Darbyshire, P.J. (2000) The UK experience in treating relapsed childhood acute lymphoblastic leukemia: a report on the Medical Research Council UKALLR1 study. British Journal of Haematology, 108, 531 543.
26. Loh, M.L. Rubnitz, J.E. (2002) TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Current Opinion in Hematology, 9, 345 352.
27. Pui, C.H., Gaynon, P.S., Boyett, J.M., Chessells, J.M., Baruchel, A., Kamps, W., Silverman, L.B., Biondi, A., Harms, D.O., Vilmer, E., Schrappe, M. Camitta, B. (2002) Outcome of treatment in childhood acute lymphoblastic leukemia with rearrangements of the 11q23 chromosomal region. Lancet, 359, 1909 1915.
28. Roy, A., Cargill, A., Love, S., Moorman, A.V., Stoneham, S., Lim, A., Darbyshire, P.J., Lancaster, D., Hann, I., Eden, T. Saha, V. (2005) Outcome after first relapse in childhood acute lymphoblastic leukemia - lessons from the United Kingdom R2 trial. British Journal of Haematology, 130, 67 75.
29. Schrappe, M., Camitta, B., Pui, C.H., Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G.E., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. Vilmer, E. (2000) Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia, 14, 2193 2194.
30. Seeger, K., Adams, H.P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C., Ritter, J., Schwabe, D., Harms, D., Schrappe, M. Henze, G. (1998) TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood, 91, 1716 1722.
31. Seeger, K., vonStackelberg, A., Taube, T., Buchwald, D., Korner, G., Suttorp, M., Dorffel, W., Tausch, W. Henze, G. (2001) Relapse of TEL-AML1-positive acute lymphoblastic leukemia in childhood: a matched pair analysis. Journal of Clinical Oncology, 19, 3188 3193.
32. Torres, A., Alvarez, M.A., Sanchez, J., Flores, R., Martinez, F., Gomez, P., Rojas, R., Herrera, C., Garcia, J.M., Andres, P., Velasco, F., Serrano, J., Roman, J., Rodriguez, A., Martin, C., Tabares, S., Rodriguez, J.M., Parody, R., Plaza, E., Leon, A., Romero, R., Jean-Paul, E., Prados, D., Aljama, R. Fernandez, A. (1999) Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second complete remission (revisited 10 years on). Bone Marrow Transplantation, 23, 1257 1260.
33. Uderzo, C., Valsecchi, M.G., Bacigalupo, A., Meloni, G., Messina, C., Polchi, P., DiGirolamo, G., Dini, G., Colella, R., Tamaro, P., Curto, M.L., Tullo, M.T.D. Masera, G. (1995) Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Pediatric Hematology Oncology Association. Journal of Clinical Oncology, 13, 352 358.
34. deVries, M.J., Veerman, A.J. Zwaan, C.M. (2004) Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin lymphoma. British Journal of Haematology, 125, 414 415.
35. Wheeler, K., Richards, S., Bailey, C. Chessells, J. (1998) Comparison of bone marrow transplant and chemotherapy for relapsed acute lymphoblastic leukaemia: the MRC UKALL X experience. British Journal of Haematology, 101, 94 103.
36. Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric aute lympholblastic leukemia by gene expression profiling. Cancer Cell, 1, 133 143.
37. Young, J.L., Gloeckler-Ries, L., Silverberg, E., Horm, J.W. Miller, R.W. (1986) Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer, 58, 598 602.
38. Zwaan, C.M., Reinhardt, D., Jürgens, H., Huismans, D.R., Hählen, K., Smith, O.P., Biondi, A., vanWering, E.R., Feingold, J. Kaspers, G.J. (2003) Gemtuzumab ozogamicin in pediatric CD-33 positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia, 17, 468 470.